About: vaccine
Japan detects no health risks in withdrawn Moderna vaccine doses from Spain
Japan has not registered for the moment any health problems in patients inoculated with the Moderna vaccine related to the contamination detected in a batch of doses from Spain, according to sources from the county’s health ministry quoted on Friday (27 August) by EURACTIV’s partner EFE.
Far right leaders want to reform EU, and the promising Sanofi vaccine
Our weekly podcast focuses on a document signed by the leaders of 16 far-right parties across the EU asking for a deep reform of the Union in order to preserve its heritage. To shed some light on what this new “coalition” brings, I spoke with EURACTIV’s Senior Editor Georgi Gotev.
Delta fears and the EU’s ‘politically suicidal’ carbon market
This week our podcast focuses on the spread of the highly contagious Delta coronavirus variant and the threat it poses to Europe’s long-awaited return to normality after almost 18 months of restrictions and lockdowns. What is the World Health Organisation...
Spanish immunologist: variants may need third vaccine dose
Spanish immunologist Carmen Álvarez-Domínguez has warned that the COVID-19 vaccines available in Spain and other EU countries could adapt to new variants, potentially necessitating a third dose in 2022, EURACTIV’s partner EFE reported.
Spain mulls lifting restrictions for hotels, restaurants, cafes
Spain's health ministry is in favour of gradually lifting restrictions for the hotel, restaurant and cafes sector known as HORECA and is mulling the reopening of nightlife activities for medium-risk regions for COVID-19. EURACTIV’s partner EFE reported.
Reshaping global health after COVID-19
The COVID-19 pandemic has cast a new light on the compelling necessity of addressing health inequalities across the globe.
Spain expects to have its own COVID-19 vaccine ready this year
Spain expects to launch a COVID-19 vaccine before the end of the year, according to Prime Minister Pedro Sánchez, who described Spanish pharmaceutical firm Hipra's vaccine candidate as one of Europe's most promising to end the pandemic, EURACTIV’s partner EFE reported.
No data currently available on mixing COVID vaccines, says EMA
There are currently no guidelines on the "mixing and matching" of COVID-19 vaccines, the European Medicines Agency (EMA) clarified on Wednesday (7 April), as several European countries are now considering mixed vaccination strategies.
The EU’s frustration over AstraZeneca and Hungary’s new Chinese jab
This week on EURACTIV’s Yellow Room, we are talking about the European Commission’s frustration over slow deliveries of the AstraZeneca vaccine and the next steps planned by the EU. To analyse the latest developments on the topic, we are joined...
Tweets of the Week: Vaccine Worries, Dutch Elections, St. Patrick’s Day
Problems with vaccines just won’t go away, D66 is here to slay and it was tricky to celebrate St Patrick’s Day.
France gets green light to use Amazon-hosted Doctolib for jab bookings
The interim relief judge of the French Council of State ruled last Friday (12 March) that the health ministry's decision to integrate medical portal Doctolib, which uses Amazon’s hosting services, into its online booking system for COVID-19 vaccinations did not infringe privacy and personal data protection rights. EURACTIV France reports.
Slovak vaccine-induced political crisis and “green” football
This week on EURACTIV’s Yellow Room, we are bringing our international network to Brussels, focusing on Slovakia’s current political situation and how it is affected by the purchase of the Russian Sputnik vaccine
Vaccine ‘travel pass’ and French trial over data protection risks
This week on EURACTIV’s Yellow Room, we are talking about the proposed vaccine “travel pass” and the controversy around it. EU countries whose economies depend on tourism seem to be eager to adopt the proposed solution, while others are more...
Commission concerned about COVID vaccines black market
European Commission President Ursula von der Leyen has warned member states that getting supplies of COVID vaccines from illicit trade entails considerable risks for human health.
Initial trial finds Russia vaccine 91.6% efficient, EU does not rule out a deal
A preliminary trial of Russia's Sputnik V COVID-19 vaccine suggests that a two-dose regimen of the vaccine offers 91.6% efficacy against symptomatic COVID-19, according to findings published on Tuesday (2 February). At the same time, the European Commission confirmed it does not rule out a deal for the vaccine.
Commission denies existence of COVID vaccine side deals
The European Commission denied on Tuesday (12 January) the existence of bilateral vaccine contracts between individual EU countries and manufacturers, saying this is not possible under the joint procurement agreement. This directly contradicts the Portuguese EU presidency, who confirmed such deals last week.
EMA director: Europeans are better protected with ‘EU licensed’ COVID vaccine
In an exclusive interview in Amsterdam with EURACTIV’s partner EFE, Emer Cooke, the executive director of the European Medicines Agency (EMA), stressed that Europeans are much “better protected" if the COVID-19 vaccine is authorised by the EU agency.
Tweets of the Week: Rule of Law, Brexit mascot and vaccine efficacy claims
Hungary and Poland scupper rule of law aims, Brexit talks seem to be going down in flames, and vaccines efficacy sparks spurious claims!
Tweets of the Week: Covid Vaccine, Imam Schools, MEP in a Bus
Covid vaccine hope is a major stock market plus, Michel’s EU school for imams causes a fuss, and an outraged MEP doesn’t want to take the bus.
UK, US and Canada accuse Russia of vaccine research hacking
Britain, the United States and Canada on Thursday (16 July) risked worsening fraught diplomatic ties with Russia by accusing Moscow-linked hackers of targeting labs in their countries conducting coronavirus vaccine research.
‘Game-changing’ vaccine against COVID-19 could still be a year away
The development of a game-changing safe and effective vaccine for the COVID-19 virus could be a year away, according to a leaked document seen by EURACTIV.com, which states that Europe will “have to live with the virus,” until such a vaccine or treatment is found.
WHO expert: Finding and distributing COVID-19 vaccine in 18 months would be ‘historic’
It would be “historic” to find a vaccine that can be distributed to all countries in 18 months to defeat the coronavirus, a high-ranking researcher at the World Health Organisation told EURACTIV’s partner EFE in an interview. “We are all...
High immunity levels matter, Andriukaitis says after vaccination debate in Italy
When it comes to vaccination and immunity, what matters is to ensure high immunity levels and not the way each EU government will decide to follow, EU Health Commissioner Vytenis Andriukaitis told EURACTIV.com following a heated debate on the issue in Italy.